ASH 43rd (2001)

Drupal spam blocked by CleanTalk.
Title Content type
Chronic Renal Failure: An Underestimated Complication of Allogeneic Bone Marrow Transplantation. (click for details)
Assessment of Maximum Tolerated Dose (MTD) and Pharmacokinetics (PK) of FK463 in Neutropenic Patients after Haematopoetic Stem Cell Transplantation. (click for details)
A Multicenter Randomized Trial by Italian Lymphoma Intergroup (ILI) Comparing High Dose Chemotherapy (HDS) with Autologous Stem Cell Transplantation (ASCT) vs Intensified Chemotherapy MegaCEOP in High Risk Diffuse Large Cell Lymphoma (DLCL): No Differenc (click for details)
A Phase I/II Study of Induction Chemotherapy with Daunorubicin, Cytarabine, Topotecan, and Etoposide (DATE) for De Novo, Relapsed or Refractory AML, or AML Arising from a Previous Phase of MDS in Treatment of Patients Ages 16-75. (click for details)
A Combined Approach of Early CT Scanning and Liposomal Amphotericin B [AmBisome] Treatment Is Associated with a High Clinical Response Rate and Low Mortality in Leukemic Patients Neutropenic from Chemotherapy Who Have Invasive Pulmonary aspergillosis. (click for details)
Radioimmunotherapy (RAIT) with 131-Iodine Labeled Rituximab in Patients with B Cell NHL in a Myeloablative and Non-Myeloablative Regimen. (click for details)
CAMPATH-1H Reduces the Risk of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation and Minimally Myelosuppressive Conditioning Treatment with Low Dose Total Body Irradiation and Cyclosporine/Mycophenolate Mofetil Immuno (click for details)
Early and Late Infectious Complications Following Unrelated Cord Blood Transplantation (UCBT). (click for details)
Autologous Stem Cell Transplants Combined with Rituximab for Relapsed Follicular Lymphoma Achieve Prolonged Clinical and Molecular Remissions. (click for details)
Elderly Patients with Aggressive Non-Hodgkin's Lymphoma (NHL): An Age Adjusted High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplantation (ASCT) Allows an Adequate PBPC Yield with Low Toxicity and Promising Results. (click for details)


Subscribe to ASH 43rd (2001)